Chromosome 1p36 Deletion Syndrome
|
0.520 |
Biomarker
|
disease |
MGD |
Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability.
|
21209188 |
2011 |
Chromosome 1p36 Deletion Syndrome
|
0.520 |
Biomarker
|
disease |
BEFREE |
Although haploinsufficiency of the potassium channel beta-subunit (KCNAB2) is thought to be responsible for intractable seizures in the 1p36 deletion syndrome, this was not the case for 3 of the 11 patients in this study.
|
16023556 |
2005 |
Chromosome 1p36 Deletion Syndrome
|
0.520 |
ChromosomalRearrangement
|
disease |
ORPHANET |
"Further delineation of novel 1p36 rearrangements by array-CGH analysis: narrowing the breakpoints and clarifying the ""extended"" phenotype."
|
22766398 |
2012 |
Chromosome 1p36 Deletion Syndrome
|
0.520 |
Biomarker
|
disease |
BEFREE |
Hemizygosity of this gene in a majority of monosomy 1p36 syndrome patients with epilepsy suggests that haploinsufficiency for KCNAB2 is a significant risk factor for epilepsy.
|
11580756 |
2001 |
Chromosome 1p36 Deletion Syndrome
|
0.520 |
Biomarker
|
disease |
MGD |
Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2).
|
11825900 |
2002 |
Chromosome 1p36 Deletion Syndrome
|
0.520 |
Biomarker
|
disease |
MGD |
Genetic modifiers of the Kv beta2-null phenotype in mice.
|
15720404 |
2005 |
Chromosome 1p36 Deletion Syndrome
|
0.520 |
ChromosomalRearrangement
|
disease |
ORPHANET |
[Effect of carbamazepine on epilepsy with 1p36 deletion syndrome].
|
17633087 |
2007 |
Epilepsy
|
0.310 |
Biomarker
|
disease |
CTD_human |
Nine patients are deleted for the KCNAB2 locus, and eight (89%) of these have epilepsy or epileptiform activity on EEG.
|
11580756 |
2001 |
Epilepsy
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Nine patients are deleted for the KCNAB2 locus, and eight (89%) of these have epilepsy or epileptiform activity on EEG.
|
11580756 |
2001 |
Epilepsy, Cryptogenic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome.
|
11580756 |
2001 |
Awakening Epilepsy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome.
|
11580756 |
2001 |
Autistic Disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Patent ductus arteriosus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fatty Liver
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gastroesophageal reflux disease
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Conductive hearing loss
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hydronephrosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypogonadism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypothyroidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microstomia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|